Sara Ramos-Romero

Dr. Sara Ramos-Romero

Physiology Section, Department of Cell Biology, Physiology & Immunology, Faculty of Biology, University of Barcelona, Barcelona, Spain
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJosé María Castellano
José María Castellano
Sara Ramos-RomeroSara Ramos-Romero
Sara Ramos-Romero
Javier Sanchez PeronaJavier Sanchez Perona
Javier Sanchez Perona
Oleanolic acid, a pentacyclic triterpenoid ubiquitously present in the plant kingdom, is receiving outstanding attention from the scientific community due to its biological activity against multiple diseases. Oleanolic acid is endowed with a wide range of biological activities with therapeutic potential by means of complex and multifactorial mechanisms. There is evidence suggesting that oleanolic acid might be effective against dyslipidemia, diabetes and metabolic syndrome, through enhancing insulin response, preserving the functionality and survival of β-cells and protecting against diabetes complications. In addition, several other functions have been proposed, including antiviral, anti-HIV, antibacterial, antifungal, anticarcinogenic, anti-inflammatory, hepatoprotective, gastroprotective, hypolipidemic and anti-atherosclerotic activities, as well as interfering in several stages of the development of different types of cancer; however, due to its hydrophobic nature, oleanolic acid is almost insoluble in water, which has led to a number of approaches to enhance its biopharmaceutical properties. In this scenario, the present review aimed to summarize the current knowledge and the research progress made in the last years on the extraction and characterization of oleanolic acid and its biological activities and the underlying mechanisms of action.

9 February 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
Sara Ramos-RomeroSara Ramos-Romero
Sara Ramos-Romero
JGJoan Ramon Torrella Guio
Joan Ramon Torrella Guio
TCTeresa Pagés Costas
Teresa Pagés Costas
Ginés ViscorGinés Viscor
Ginés Viscor
JTJosep Lluís Torres
Josep Lluís Torres
Marine and freshwater algae and their products are in growing demand worldwide because of their nutritional and functional properties. Microalgae (unicellular algae) will constitute one of the major foods of the future for nutritional and environmental reasons. They are sources of high-quality protein and bioactive molecules with potential application in the modern epidemics of obesity and diabetes. They may also contribute decisively to sustainability through carbon dioxide fixation and minimization of agricultural land use. This paper reviews current knowledge of the effects of consuming edible microalgae on the metabolic alterations known as metabolic syndrome (MS). These microalgae include Chlorella, Spirulina (Arthrospira) and Tetraselmis as well as Isochrysis and Nannochloropsis as candidates for human consumption. Chlorella biomass has shown antioxidant, antidiabetic, immunomodulatory, antihypertensive, and antihyperlipidemic effects in humans and other mammals. The components of microalgae reviewed suggest that they may be effective against MS at two levels: in the early stages, to work against the development of insulin resistance (IR), and later, when pancreatic -cell function is already compromised. The active components at both stages are antioxidant scavengers and anti-inflammatory lipid mediators such as carotenoids and -3 PUFAs (eicosapentaenoic acid/docosahexaenoic acid; EPA/DHA), prebiotic polysaccharides, phenolics, antihypertensive peptides, several pigments such as phycobilins and phycocyanin, and some vitamins, such as folate. As a source of high-quality protein, including an array of bioactive molecules with potential activity against the modern epidemics of obesity and diabetes, microalgae are proposed as excellent foods for the future. Moreover, their incorporation into the human diet would decisively contribute to a more sustainable world because of their roles in carbon dioxide fixation and reducing the use of land for agricultural purposes.

1 August 2008 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
EREmma Ramiro-Puig
Emma Ramiro-Puig
Francisco José PerezFrancisco José Perez
Francisco José Perez
Sara Ramos-RomeroSara Ramos-Romero
Sara Ramos-Romero
TPTeresa Pérez-Berezo
Teresa Pérez-Berezo
CCCristina Castellote
Cristina Castellote
Margarida CastellMargarida Castell
Margarida Castell

4 November 2015 in ACS Chemical Biology
Verified
Journal Article
Closed access
Dhanya Thamaraparambil JayaramDhanya Thamaraparambil Jayaram
Dhanya Thamaraparambil Jayaram
Sara Ramos-RomeroSara Ramos-Romero
Sara Ramos-Romero
BSBalaraman H. Shankar
Balaraman H. Shankar
CGCristina Garrido
Cristina Garrido
NRNuria Rubio
Nuria Rubio
DRDanaboyina Ramaiah
Danaboyina Ramaiah

27 February 2015 in British Journal of Nutrition
Verified
Journal Article
Closed access
EMEunice Molinar-Toribio
Eunice Molinar-Toribio
JPJara Pérez-Jiménez
Jara Pérez-Jiménez
Sara Ramos-RomeroSara Ramos-Romero
Sara Ramos-Romero
MRMarta Romeu
Marta Romeu
MGMontse Giralt
Montse Giralt
JTJosep Lluís Torres
Josep Lluís Torres
The increasing incidence of the metabolic syndrome (MetS), a combination of risk factors before the onset of CVD and type 2 diabetes, encourages studies on the role of functional food components such as long-chainn-3 PUFA as preventive agents. In the present study, we explore the effect of EPA and DHA supplementation in different proportions on spontaneously hypertensive obese (SHROB) rats, a model for the MetS in a prediabetic state with mild oxidative stress. SHROB rats were randomised into four groups (n7), each supplemented with EPA/DHA at ratios of 1:1, 2:1 and 1:2, or soyabean oil as the control for 13 weeks. The results showed that in all the proportions tested, EPA/DHA supplementation significantly lowered total and LDL-cholesterol concentrations, compared with those of the control group. EPA/DHA supplementation at the ratios of 1:1 and 2:1 significantly decreased inflammation (C-reactive protein levels) and lowered oxidative stress (decreased excretion of urinary isoprostanes), mainly at the ratio of 1:2. The activity of antioxidant enzymes increased in erythrocytes, abdominal fat and kidneys, with magnitudes depending on the EPA:DHA ratio. PUFA mixtures from fish affected different MetS markers of CVD risk factors in SHROB rats, depending on the ratios of EPA/DHA supplementation. The activation of endogenous defence systems may be related to the reduction of inflammation and oxidative stress.

1 June 2018 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
Sara Ramos-RomeroSara Ramos-Romero
Sara Ramos-Romero
MHMercè Hereu
Mercè Hereu
LALidia Atienza
Lidia Atienza
JCJosefina Casas
Josefina Casas
OJOlga Jáuregui
Olga Jáuregui
JTJosep Lluís Torres
Josep Lluís Torres
Insulin resistance (IR) and impaired glucose tolerance (IGT) are the first manifestations of diet-induced metabolic alterations leading to Type 2 diabetes, while hypertension is the deadliest risk factor of cardiovascular disease. The roles of dietary fat and fructose in the development of IR, IGT, and hypertension are controversial. We tested the long-term effects of an excess of fat or sucrose (fructose/glucose) on healthy male Wistar-Kyoto (WKY) rats. Fat affects IR and IGT earlier than fructose through low-grade systemic inflammation evidenced by liver inflammatory infiltration, increased levels of plasma IL-6, PGE2, and reduced levels of protective short-chain fatty acids without triggering hypertension. Increased populations of gut Enterobacteriales and Escherichia coli may contribute to systemic inflammation through the generation of lipopolysaccharides. Unlike fat, fructose induces increased levels of diacylglycerols (lipid mediators of IR) in the liver, urine F2-isoprostanes (markers of systemic oxidative stress), and uric acid, and triggers hypertension. Elevated populations of Enterobacteriales and E. coli were only detected in rats given an excess of fructose at the end of the study. Dietary fat and fructose trigger IR and IGT in clearly differentiated ways in WKY rats: early low-grade inflammation and late direct lipid toxicity, respectively; gut microbiota plays a role mainly in fat-induced IR, and hypertension is independent of inflammation-mediated IR. The results provide evidence that suggests that the combination of fat and sugar is potentially more harmful than fat or sugar alone when taken in excess.